Active

Intrexon Actobiotics

Switched

BE0882251820

Rechtspersoon Public limited company 1 establishment

Oudenaardseheerweg 129, 9810 Nazareth-De Pinte Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

20 year, 2 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Gross margin

€ -217,049

▼ 136% vs 2024

Profit

Caution

€ -372,153

▲ 85% vs 2024

Debts

Low

€ 170,895

▼ 79% vs 2024

Intrexon Actobiotics from Nazareth-De Pinte, company number BE0882251820, closed financial year 2025 with a result of € -372,153 after tax. For that financial year Intrexon Actobiotics recorded a gross margin of € -217,049 and equity of € 8.6 million. Compared with financial year 2024, the result moved from € -2.5 million to € -372,153. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What happened at Intrexon Actobiotics?

What happened at Intrexon Actobiotics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Rutul Shah stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 372,153. Source: NBB ↗
  • Donald Lehr stepped down as director. NBB
  • Rutul Shah became a director. NBB
  • Donald Lehr became a director. NBB
  • New establishment in Nazareth-De Pinte. KBO
  • Start of the company according to the CBE. KBO

In short

From € 939,460 profit in 2021 to € 372,153 loss in 2025.

Paid € 10,955 in corporate taxes since 2021.

Best year ever: 2021, with € 939,460 profit.

On average € 55,900 of value added per employee in 2024.

A new publication or filing at Intrexon Actobiotics? We notify you, reason included.

Follow Intrexon Actobiotics

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

Rutul Shah

Director

since 2024 · until 2030

Donald Lehr

Director

Also active at: ACTOBIO LABORATORIES BELGIUM

since 2020 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Oudenaardseheerweg 129

9810 Nazareth-De Pinte

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.

+4 more

Details

Company number
0882.251.820
VAT number
BE 0882.251.820
Registered office
Oudenaardseheerweg 129, 9810 Nazareth-De Pinte
Names & denominations
Intrexon Actobiotics
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
3 July 2006
Peppol
Active · Active since 18 Sept 2024
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Frequently asked questions

What is the enterprise number of Intrexon Actobiotics?
The enterprise number of Intrexon Actobiotics is BE0882251820.
What is the address of Intrexon Actobiotics?
The registered office of Intrexon Actobiotics is located at Oudenaardseheerweg 129, 9810 Nazareth-De Pinte.
When was Intrexon Actobiotics founded?
Intrexon Actobiotics was founded on 3 July 2006.
What is the main activity of Intrexon Actobiotics?
The main activity of Intrexon Actobiotics is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does Intrexon Actobiotics have a website?
No website is currently known for Intrexon Actobiotics.
How much profit did Intrexon Actobiotics make in 2025?
Intrexon Actobiotics recorded a loss after taxes of € 372,153 in financial year 2025.
What is the revenue of Intrexon Actobiotics?
As a small company, Intrexon Actobiotics is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -217,049.
Where can I find the annual accounts of Intrexon Actobiotics?
Intrexon Actobiotics files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Intrexon Actobiotics?
According to the 2025 annual accounts, the directors of Intrexon Actobiotics are: Rutul Shah, Donald Lehr.